INSR and metabolic syndrome: MG53 is protective in cardiac ischemia/reperfusion injury, cardiomyocyte membrane injury, and cardiac fibrosis, but it simultaneously acts as an E3 ligase to promote ubiquitin dependent degradation of the insulin receptor and insulin receptor substrate, leading to insulin resistance and metabolic syndrome (59, 60).